Clinical Leader Webinar

  1. Uncover Pharmacovigilance Insights With Data Discovery And Active Surveillance
    10/4/2017

    This webcast discusses how drug safety teams can use dynamic visual analytics to uncover safety issues earlier. All the while, complying with extremely complex and ever-evolving regulatory requirements.

  2. Propel Medical Review With Guided Analytics
    10/4/2017

    This webcast discusses how medical monitors can leverage guided visual analytics to find and act on the right issues quickly without sifting through mounds of clinical data.

  3. How To Select The Most Effective eCOA Modality For Your Study
    10/4/2017

    Understand the benefits and challenges of each modality used in clinical trials today, items to consider when choosing an eCOA modality, as well as tips for successful eCOA modality selection.

  4. Planning And Conducting Trials Of The Latest Immunotherapies
    9/12/2017

    In this webinar, INC Research/inVentiv Health experts discuss the factors that sponsors must take into account as they design and execute clinical trials in this space, beginning with a review of the immunotherapy landscape.

  5. Are Delays In Clinical Trials Due To A Lack Of Experienced CRAs?
    9/1/2017

    The webinar focuses issues and bottlenecks that contribute to delays that are outside of the CRA control.

  6. Why Are Metrics Important In Starting Clinical Trials?
    9/1/2017

    The webinar will focus on these issues and the competitive edge metrics provide those organizations engaged in conducting clinical trials.

  7. New Tufts CSDD Study On End-To-End Site Identification Through Startup
    8/31/2017

    This webinar covers the study assessing sponsor and CRO experience, practices and improvement areas associated with investigative site identification, feasibility, selection and study startup.

  8. Electronic Informed Consent: 2017 Industry Survey
    6/21/2017

    Presenters: Naor Chazan, Director of Marketing (but no longer with the company, FYI) and Sandra “SAM” Sather, Quality and Regulatory, TrialConsent) CRF Health's State of eConsent 2017 Report surveyed 100 biotech, pharmaceutical, CRO, and IRB organizations who shared their opinions on Electronic Informed Consent (eConsent). During this webinar, industry expert, Sandra "Sam" Sather, Regulatory and Quality Lead for TrialConsentTM at CRF Health, discusses the results.

  9. Evidence-Based Approaches For Accelerating Patient Enrollment In Oncology
    6/2/2017

    The number of oncology clinical trials has increased exponentially in recent years, putting ever more pressure on increasing clinical trial efficiency by reducing costs and timelines. Patient recruitment swallows 40% of trial costs, yet only 10–17% of studies enroll on time and approximately 11% of sites in any given study fail to enroll a single patient.

  10. Implementing Basket/Bucket And Umbrella Designs: What You Need to Know For Global Oncology Trials
    6/2/2017

    Recent successes in the treatment of cancer have led to more complex trials such as master protocols using basket (or bucket) and umbrella designs. These combination designs, with or without cancer immunotherapy treatments, require careful deliberations to optimize dosages and include multiple tumor types in expansion cohorts. Making informed decisions in study design for your basket/bucket or umbrella trials requires relevant and timely evidence-based data.